The efficacy and safety of lower-dose aspirin for primary and secondary prevention of cardiovascular disease in the elderly: an interim analysis of a multicenter, prospective, observational study

Aspirin 50 mg/day was associated with lower hemorrhage and gastrointestinal adverse event risks, with similar cardiovascular benefits, compared with aspirin 100 mg/day, and may be preferred to balance efficacy and safety for older Chinese adults in primary and secondary CVD prevention.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-01-12
DOI
https://doi.org/10.3389/fcvm.2025.1615074
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy and safety of lower-dose aspirin for primary and secondary prevention of cardiovascular disease in the elderly: an interim analysis of a multicenter, prospective, observational study

Xiting Wang, Xiulian Yan, Q Q Zhang, X. Liu et al.
Frontiers in Cardiovascular Medicine
Antiplatelet Therapy and Cardiovascular Diseases
article

The efficacy and safety of lower-dose aspirin for primary and secondary prevention of cardiovascular disease in the elderly: an interim analysis of a multicenter, prospective, observational study

Xiting Wang, Xiulian Yan, Q Q Zhang, X. Liu, Xuefen Qian, Huaizhong Zhang, Qing Liu, Zhangyong Xia, Sainan Zhu, Y. Sun, Xibo Sun, M. Liu, Pida Hao, Hongwei Li, Bo Liu, Jianchun Wang, Ya Wang, Xia, Yingwu Liu, Aiping Jin, Zhenghua Zhang, Xiaoping Chen, Lili Liu, Yuan Wu, Hong Qi, Wei Miao, Yong Liu, Tao Tian, Peng Dou, Jiuyu Yang, Keshan Liang, Huanyu Guo, Hongliang Cong, Jianwei He, Longmei Zhao, Yingxin Zhao, Zhengxiang Zhang, Yan Hou, Jie Hu, Nabuqi He
article en

Abstract

Aspirin 50 mg/day was associated with lower hemorrhage and gastrointestinal adverse event risks, with similar cardiovascular benefits, compared with aspirin 100 mg/day, and may be preferred to balance efficacy and safety for older Chinese adults in primary and secondary CVD prevention.

Frontiers in Cardiovascular MedicineVol. 12
Jiangsu University (CN), Binzhou Medical University (CN), Shandong University of Aeronautics (CN), Capital Medical University (CN), Chifeng University (CN), Peking University (CN), Tianjin Third Central Hospital (CN), First People’s Hospital of Jingmen (CN), The Fourth People's Hospital of Zibo City (CN), People’s Hospital of Rizhao (CN), Linyi People's Hospital (CN), Xuzhou Cancer Hospital (CN), Jinan Central Hospital (CN), Jiangxi Provincial People's Hospital (CN), Second Affiliated Hospital of Inner Mongolia Medical University (CN), Tianjin People's Hospital (CN), Shandong Provincial Hospital (CN), Beijing Anzhen Hospital (CN), Linzi District People's Hospital (CN), Chifeng Municipal Hospital (CN), Linyi City Chinese Medicine Hospital (CN), Yidu Central Hospital of Weifang (CN), The First People’s Hospital of Lianyungang (CN), Wuhan Union Hospital (CN), Peking University First Hospital (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Yancheng Second People's Hospital (CN), Taiyuan Central Hospital (CN), Tianjin Fourth Hospital (CN), Central Hospital of Zibo (CN), Tianjin Chest Hospital (CN), Tang Hospital (CN), Liaocheng People's Hospital (CN), Shandong First Medical University (CN), Union Hospital (CN), Tianjin Medical University (CN), Zhejiang University (CN)
Peking University First Hospital, Peking University
Good health and well-being
Openalex Percentile: Top 92%
Antiplatelet Therapy and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.